Southern Africa — Gus Attridge — South Africa — Johannesburg Stock Exchange — Aspen Pharmacare — Hot News
Gus Attridge’s stake in Africa’s largest pharma company drops by $16.5 million
South African pharma mogul Gus Attridge loses $16.5 million from stake in Africa’s largest pharmaceutical company.
Related
Stephen Saad’s Aspen faces $148.7 million contract dispute
Aspen shares dive 30% amid $148.7 million mRNA tech dispute, stoking investor fears over financial stability.
Capitec to pay $47.6 million to three South African shareholders
Capitec to pay $47.6 million to three South African shareholders
Gerrie Fourie’s salary at Capitec Bank totals $5.6 million
This reflects his role in steering the bank through a period of significant growth, strengthening its position as a leader in the country’s financial sector.
Dominic Sewela's Barloworld $1.2 billion bid gets PIC backing
The PIC has pledged its support by agreeing to accept a standby offer for 41.6 million Barloworld shares, which translates to 21.93 percent of the company’s total issued shares.
Latest
Peter Ndegwa leads Safaricom’s $300 million M-PESA upgrade
Peter Ndegwa said the upgrade will strengthen M-PESA’s backbone, making it more resilient and prepared for the future.
Lamia Tazi gains $14 million from Sothema stake in 18 days
This upswing has further cemented her position among Morocco’s wealthiest individuals.
Meet Ahonsi Unuigbe, Nigerian energy mogul with hidden $70 million oil stake in Canada
With over two decades of experience across industries, Unuigbe, CEO of Petralon Energy, is a leading energy mogul in Africa.
Peter Munga reclaims Equity Group stake with $1.3 million new shares
The move boosts his direct stake in East Africa’s largest lender at a time when the bank continues to post strong results and maintain its market dominance.